Skip to Main Content

Advertisement

Umbrella Alt Text
Cart
header search
Search
Skip Nav Destination

Issue Archive

Volume 6, Issue 6
March 22 2022
Issue Cover

Table of Contents

EXCEPTIONAL CASE REPORT

Successful outcome of pre-engraftment COVID-19 in an HCT patient: impact of targeted therapies and cellular immunity
Hoda Pourhassan,Corinna La Rosa,Flavia Chiuppesi,Alfredo Puing,Ibrahim Aldoss,Yoonsuh Park,Qiao Zhou,Veronica Karpinski,Katelyn Faircloth,Teodora Kaltcheva,Daisy Johnson,Sandra Ortega Francisco,John A. Zaia,Ryotaro Nakamura,Monzr M. Al Malki,Don J. Diamond,Sanjeet Singh Dadwal,Stephen J. Forman
View Articletitled, Successful outcome of pre-engraftment COVID-19 in an HCT patient: impact of targeted therapies and cellular immunity
Supplemental data

STIMULUS REPORT

Prevalence and variation of CHIP in patients with aggressive lymphomas undergoing CD19-directed CAR T-cell treatment
Clinical Trials & Observations
Raphael Teipel,Frank Kroschinsky,Michael Kramer,Theresa Kretschmann,Katharina Egger-Heidrich,Thomas Krüger,Leo Ruhnke,Sylvia Herold,Sebastian Stasik,Katja Sockel,Jan M. Middeke,Karolin Trautmann-Grill,Martin Bornhäuser,Christian Thiede,Malte von Bonin
View Articletitled, Prevalence and variation of CHIP in patients with aggressive lymphomas undergoing CD19-directed CAR T-cell treatment
Supplemental data

REVIEW ARTICLE

Clinical features, pathophysiology, and therapy of poor graft function post–allogeneic stem cell transplantation
Ashvind Prabahran,Rachel Koldej,Lynette Chee,David Ritchie
View Articletitled, Clinical features, pathophysiology, and therapy of poor graft function post–allogeneic stem cell transplantation

CLINICAL TRIALS AND OBSERVATIONS

Zanubrutinib monotherapy for relapsed or refractory non-germinal center diffuse large B-cell lymphoma
Clinical Trials & Observations
Haiyan Yang,Bing Xiang,Yuqin Song,Huilai Zhang,Weili Zhao,Dehui Zou,Fangfang Lv,Wei Guo,Aichun Liu,Caixia Li,Ziwen Tan,Yang Liu,Lina Fu,Haiyi Guo,William Novotny,Jane Huang,Yufu Li
View Articletitled, Zanubrutinib monotherapy for relapsed or refractory non-germinal center diffuse large B-cell lymphoma
Supplemental data
Risk profiling of patients with relapsed/refractory diffuse large B-cell lymphoma by measuring circulating tumor DNA
Clinical Trials & Observations
Alex F. Herrera,Samuel Tracy,Brandon Croft,Stephen Opat,Jill Ray,Alex F. Lovejoy,Lisa Musick,Joseph N. Paulson,Laurie H. Sehn,Yanwen Jiang
View Articletitled, Risk profiling of patients with relapsed/refractory diffuse large B-cell lymphoma by measuring circulating tumor DNA
Supplemental data
Apixaban compared with warfarin to prevent thrombosis in thrombotic antiphospholipid syndrome: a randomized trial
Clinical Trials & Observations
Scott C. Woller,Scott M. Stevens,David Kaplan,Tzu-Fei Wang,D. Ware Branch,Danielle Groat,Emily L. Wilson,Brent Armbruster,Valerie T. Aston,James F. Lloyd,Matthew T. Rondina,C. Greg Elliott
View Articletitled, Apixaban compared with warfarin to prevent thrombosis in thrombotic antiphospholipid syndrome: a randomized trial
Supplemental data
Analysis of racial and ethnic disparities in multiple myeloma US FDA drug approval trials
Clinical Trials & Observations
Bindu Kanapuru,Laura L. Fernandes,Lola A. Fashoyin-Aje,Andrea C. Baines,Vishal Bhatnagar,Rachel Ershler,Thomas Gwise,Paul Kluetz,Richard Pazdur,Elizabeth Pulte,Yuan-Li Shen,Nicole Gormley
View Articletitled, Analysis of racial and ethnic disparities in multiple myeloma US FDA drug approval trials
Supplemental data
BTK inhibitors impair humoral and cellular responses to recombinant zoster vaccine in CLL
Clinical Trials & Observations
Christopher Pleyer,Kerry J. Laing,Mir A. Ali,Christopher L. McClurkan,Susan Soto,Inhye E. Ahn,Pia Nierman,Emeline Maddux,Jennifer Lotter,Jeanine Superata,Xin Tian,Adrian Wiestner,Jeffrey I. Cohen,David M. Koelle,Clare Sun
View Articletitled, BTK inhibitors impair humoral and cellular responses to recombinant zoster vaccine in CLL
Supplemental data
INCB84344-201: Ponatinib and steroids in frontline therapy for unfit patients with Ph+ acute lymphoblastic leukemia
Clinical Trials & Observations
Giovanni Martinelli,Cristina Papayannidis,Alfonso Piciocchi,Valentina Robustelli,Simona Soverini,Carolina Terragna,Giovanni Marconi,Roberto M. Lemoli,Fabio Guolo,Antonella Fornaro,Monia Lunghi,Paolo de Fabritiis,Anna Candoni,Carmine Selleri,Federico Simonetti,Monica Bocchia,Antonella Vitale,Luca Frison,Alessandra Tedeschi,Antonio Cuneo,Massimiliano Bonifacio,Maria Paola Martelli,Stefano D’Ardia,Silvia Trappolini,Patrizia Tosi,Piero Galieni,Francesco Fabbiano,Maria Chiara Abbenante,Muriel Granier,Zhaoyin Zhu,Mingyue Wang,Chiara Sartor,Stefania Paolini,Michele Cavo,Robin Foà,Paola Fazi,Marco Vignetti,Michele Baccarani
View Articletitled, INCB84344-201: Ponatinib and steroids in frontline therapy for unfit patients with Ph<sup>+</sup> acute lymphoblastic leukemia
Anti-glycoprotein antibodies and sequestration pattern of indium-labeled platelets in immune thrombocytopenia
Clinical Trials & Observations
Sufia N. Amini,Leendert Porcelijn,Annemieke Sobels,Marina Kartachova,Masja de Haas,Jaap Jan Zwaginga,Martin R. Schipperus
View Articletitled, Anti-glycoprotein antibodies and sequestration pattern of indium-labeled platelets in immune thrombocytopenia
Supplemental data
A prognostic model to predict survival after 6 months of ruxolitinib in patients with myelofibrosis
Clinical Trials & Observations
Margherita Maffioli,Barbara Mora,Somedeb Ball,Alessandra Iurlo,Elena Maria Elli,Maria Chiara Finazzi,Nicola Polverelli,Elisa Rumi,Marianna Caramella,Maria Cristina Carraro,Mariella D’Adda,Alfredo Molteni,Cinzia Sissa,Francesca Lunghi,Alessandro Vismara,Marta Ubezio,Anna Guidetti,Sabrina Caberlon,Michela Anghilieri,Rami Komrokji,Daniele Cattaneo,Matteo Giovanni Della Porta,Toni Giorgino,Lorenza Bertù,Marco Brociner,Andrew Kuykendall,Francesco Passamonti
View Articletitled, A prognostic model to predict survival after 6 months of ruxolitinib in patients with myelofibrosis
Supplemental data

HEMATOPOIESIS AND STEM CELLS

The bacterial microbiota regulates normal hematopoiesis via metabolite-induced type 1 interferon signaling
Hannah Yan,Forrest C. Walker,Arushana Ali,Hyojeong Han,Lin Tan,Lucas Veillon,Philip L. Lorenzi,Megan T. Baldridge,Katherine Y. King
View Articletitled, The bacterial microbiota regulates normal hematopoiesis via metabolite-induced type 1 interferon signaling
Supplemental data
Deleterious effect of bone marrow-resident macrophages on hematopoietic stem cells in response to total body irradiation
Marion Chalot,Vilma Barroca,Saiyirami Devanand,Françoise Hoffschir,Paul-Henri Romeo,Stéphanie G. Moreno
View Articletitled, Deleterious effect of bone marrow-resident macrophages on hematopoietic stem cells in response to total body irradiation
Supplemental data
Genetic barcoding systematically compares genes in del(5q) MDS and reveals a central role for CSNK1A1 in clonal expansion
Ursula S. A. Stalmann,Fabio Ticconi,Inge A. M. Snoeren,Ronghui Li,Hélène F. E. Gleitz,Glenn S. Cowley,Marie E. McConkey,Aaron B. Wong,Stephani Schmitz,Stijn N. R. Fuchs,Shubhankar Sood,Nils B. Leimkühler,Sergio Martinez-Høyer,Bella Banjanin,David Root,Tim H. Brümmendorf,Juliette E. Pearce,Andreas Schuppert,Eric M. J. Bindels,Marieke A. Essers,Dirk Heckl,Thomas Stiehl,Ivan G. Costa,Benjamin L. Ebert,Rebekka K. Schneider
View Articletitled, Genetic barcoding systematically compares genes in del(5q) MDS and reveals a central role for <em>CSNK1A1</em> in clonal expansion
Supplemental data
A biomarker panel for risk of early respiratory failure following hematopoietic cell transplantation
Clinical Trials & Observations
Courtney M. Rowan,Lincoln Smith,Matthew P. Sharron,Laura Loftis,Sapna Kudchadkar,Christine N. Duncan,Francis Pike,Paul A. Carpenter,David Jacobsohn,Catherine M. Bollard,Conrad Russell Y. Cruz,Abhijeet Malatpure,Sherif Farag,Jamie Renbarger,Morgan R. Little,Phillip R. Gafken,Robert A. Krance,Kenneth R. Cooke,Sophie Paczesny
View Articletitled, A biomarker panel for risk of early respiratory failure following hematopoietic cell transplantation
Supplemental data

IMMUNOBIOLOGY AND IMMUNOTHERAPY

4-1BBL–containing leukemic extracellular vesicles promote immunosuppressive effector regulatory T cells
Julian Swatler,Laura Turos-Korgul,Marta Brewinska-Olchowik,Sara De Biasi,Wioleta Dudka,Bac Viet Le,Agata Kominek,Salwador Cyranowski,Paulina Pilanc,Elyas Mohammadi,Dominik Cysewski,Ewa Kozlowska,Wioleta Grabowska-Pyrzewicz,Urszula Wojda,Grzegorz Basak,Jakub Mieczkowski,Tomasz Skorski,Andrea Cossarizza,Katarzyna Piwocka
View Articletitled, 4-1BBL–containing leukemic extracellular vesicles promote immunosuppressive effector regulatory T cells
Supplemental data
Deletion of Y chromosome before allogeneic hematopoietic stem cell transplantation in male recipients with female donors
Masaharu Tamaki,Kazuaki Kameda,Shun-ichi Kimura,Naonori Harada,Naoyuki Uchida,Noriko Doki,Masatsugu Tanaka,Kazuhiro Ikegame,Masashi Sawa,Yuta Katayama,Shigesaburo Miyakoshi,Takahide Ara,Junya Kanda,Makoto Onizuka,Takahiro Fukuda,Yoshiko Atsuta,Yoshinobu Kanda,Kimikazu Yakushijin,Hideki Nakasone
View Articletitled, Deletion of Y chromosome before allogeneic hematopoietic stem cell transplantation in male recipients with female donors
Supplemental data
Hypermethylation at the CXCR5 gene locus limits trafficking potential of CD8+ T cells into B-cell follicles during HIV-1 infection
Clinical Trials & Observations
Funsho J. Ogunshola,Werner Smidt,Anneta F. Naidoo,Thandeka Nkosi,Thandekile Ngubane,Trevor Khaba,Omolara O. Baiyegunhi,Bongiwe Mahlobo,Sam Rasehlo,Namani Ngema,Ismail Jajbhay,Krista L. Dong,Veron Ramsuran,Johan Pansegrouw,Thumbi Ndung’u,Bruce D. Walker,Tulio de Oliveria,Zaza M. Ndhlovu
View Articletitled, Hypermethylation at the <em>CXCR5</em> gene locus limits trafficking potential of CD8<sup>+</sup> T cells into B-cell follicles during HIV-1 infection
Supplemental data

LYMPHOID NEOPLASIA

Humoral and cellular immunogenicity of SARS-CoV-2 vaccines in chronic lymphocytic leukemia: a prospective cohort study
Clinical Trials & Observations
J. Erika Haydu,Jenny S. Maron,Robert A. Redd,Kathleen M. E. Gallagher,Stephanie Fischinger,Jeffrey A. Barnes,Ephraim P. Hochberg,P. Connor Johnson,R. W. Takvorian,Katelin Katsis,Daneal Portman,Jade Ruiters,Sidney Sechio,Mary Devlin,Connor Regan,Kimberly G. Blumenthal,Aleena Banerji,Allen D. Judd,Krista J. Scorsune,Brianne M. McGree,Maryanne M. Sherburne,Julia M. Lynch,James I. Weitzman,Matthew Lei,Camille N. Kotton,Anand S. Dighe,Marcela V. Maus,Galit Alter,Jeremy S. Abramson,Jacob D. Soumerai
View Articletitled, Humoral and cellular immunogenicity of SARS-CoV-2 vaccines in chronic lymphocytic leukemia: a prospective cohort study
Supplemental data
CD158k and PD-1 expressions define heterogeneous subtypes of Sezary syndrome
Inès Vergnolle,Claudia Douat-Beyries,Serge Boulinguez,Jean-Baptiste Rieu,Jean-Philippe Vial,Rolande Baracou,Sylvie Boudot,Aurore Cazeneuve,Sophie Chaugne,Martine Durand,Sylvie Estival,Nicolas Lablanche,Marie-Laure Nicolau-Travers,Emilie Tournier,Laurence Lamant,François Vergez
View Articletitled, CD158k and PD-1 expressions define heterogeneous subtypes of Sezary syndrome
Supplemental data
Checkpoint protein expression in the tumor microenvironment defines the outcome of classical Hodgkin lymphoma patients
Clinical Trials & Observations
Kristiina Karihtala,Suvi-Katri Leivonen,Marja-Liisa Karjalainen-Lindsberg,Fong Chun Chan,Christian Steidl,Teijo Pellinen,Sirpa Leppä
View Articletitled, Checkpoint protein expression in the tumor microenvironment defines the outcome of classical Hodgkin lymphoma patients
Supplemental data

MYELOID NEOPLASIA

BCL11A promotes myeloid leukemogenesis by repressing PU.1 target genes
Yoshitaka Sunami,Takashi Yokoyama,Seiko Yoshino,Tomoko Takahara,Yukari Yamazaki,Hironori Harada,Takuro Nakamura
View Articletitled, BCL11A promotes myeloid leukemogenesis by repressing PU.1 target genes
Supplemental data

PHAGOCYTES, GRANULOCYTES, AND MYELOPOIESIS

Lysosomal iron recycling in mouse macrophages is dependent upon both LcytB and Steap3 reductases
Fanjing Meng,Brittany A. Fleming,Xuan Jia,Alexis A. Rousek,Matthew A. Mulvey,Diane M. Ward
View Articletitled, Lysosomal iron recycling in mouse macrophages is dependent upon both LcytB and Steap3 reductases
Supplemental data

PLATELETS AND THROMBOPOIESIS

COVID-19 vaccination in patients with immune thrombocytopenia
Clinical Trials & Observations
Chantal Visser,Maurice Swinkels,Erik D. van Werkhoven,F. Nanne Croles,Heike S. Noordzij-Nooteboom,Matthijs Eefting,Suzanne M. Last-Koopmans,Cecile Idink,Peter E. Westerweel,Bart Santbergen,Pieter A. Jobse,Fazil Baboe,RECOVAC-IR Consortium,Peter A. W. te Boekhorst,Frank W. G. Leebeek,Mark-David Levin,Marieke J. H. A. Kruip,A. J. Gerard Jansen
View Articletitled, COVID-19 vaccination in patients with immune thrombocytopenia
Supplemental data

RED CELLS, IRON, AND ERYTHROPOIESIS

Health-related quality of life and fatigue in children and adults with pyruvate kinase deficiency
Clinical Trials & Observations
Hanny Al-Samkari,Eduard J. van Beers,D. Holmes Morton,Stefan W. Eber,Satheesh Chonat,Kevin H. M. Kuo,Nina Kollmar,Heng Wang,Vicky R. Breakey,Sujit Sheth,Mukta Sharma,Peter W. Forbes,Robert J. Klaassen,Rachael F. Grace
View Articletitled, Health-related quality of life and fatigue in children and adults with pyruvate kinase deficiency
Supplemental data

THROMBOSIS AND HEMOSTASIS

Extent of intravital contraction of arterial and venous thrombi and pulmonary emboli
Rafael R. Khismatullin,Shahnoza Abdullayeva,Alina D. Peshkova,Khetam Sounbuli,Natalia G. Evtugina,Rustem I. Litvinov,John W. Weisel
View Articletitled, Extent of intravital contraction of arterial and venous thrombi and pulmonary emboli
Supplemental data

TRANSPLANTATION

Clofarabine-fludarabine-busulfan in HCT for pediatric leukemia: an effective, low toxicity, TBI-free conditioning regimen
Clinical Trials & Observations
A. Birgitta Versluijs,Coco C. H. de Koning,Arjan C. Lankester,Stefan Nierkens,Wouter J. Kollen,Dorine Bresters,Caroline A. Lindemans,Jaap Jan Boelens,Marc Bierings
View Articletitled, Clofarabine-fludarabine-busulfan in HCT for pediatric leukemia: an effective, low toxicity, TBI-free conditioning regimen
Supplemental data
In-depth time-dependent analysis of the benefit of allo-HSCT for elderly patients with CR1 AML: a FILO study
Clinical Trials & Observations
Raynier Devillier,Edouard Forcade,Alice Garnier,Sarah Guenounou,Sylvian Thepot,Gaelle Guillerm,Patrice Ceballos,Yosr Hicheri,Pierre-Yves Dumas,Pierre Peterlin,Mathilde Hunault-Berger,Marie-Christine Béné,Anne Bouvier,Patrice Chevallier,Didier Blaise,Norbert Vey,Arnaud Pigneux,Christian Récher,Anne Huynh
View Articletitled, In-depth time-dependent analysis of the benefit of allo-HSCT for elderly patients with CR1 AML: a FILO study
Supplemental data

RESEARCH LETTER

Expression of activated B-cell gene signature is predictive of the outcome of follicular lymphoma
Taku Tsukamoto,Yuichi Tokuda,Masakazu Nakano,Kei Tashiro,Junya Kuroda
View Articletitled, Expression of activated B-cell gene signature is predictive of the outcome of follicular lymphoma
Supplemental data
Annual decline in lung function in adults with sickle cell disease is similar to that observed in adults with cystic fibrosis
Clinical Trials & Observations
Brock Hodges,Zalaya Ivy,Robert M. Cronin,Mark Rodeghier,Michael R. DeBaun,Shaina M. Willen
View Articletitled, Annual decline in lung function in adults with sickle cell disease is similar to that observed in adults with cystic fibrosis
Supplemental data

COMMENTARY

TP53-mutant myelodysplastic syndrome and acute myeloid leukemia: the black hole of hematology
Shyam A. Patel,Jan Cerny
View Articletitled, <em>TP53</em>-mutant myelodysplastic syndrome and acute myeloid leukemia: the black hole of hematology

ERRATA

Pasquini MC, Hu Z-H, Curran K, et al. Real-world evidence of tisagenlecleucel for pediatric acute lymphoblastic leukemia and non-Hodgkin lymphoma. Blood Adv. 2020;4(21):5414-5424.
View Articletitled, Pasquini MC, Hu Z-H, Curran K, et al. Real-world evidence of tisagenlecleucel for pediatric acute lymphoblastic leukemia and non-Hodgkin lymphoma. <em>Blood Adv.</em> 2020;4(21):5414-5424.
Olin RL, Fretham C, Pasquini MC, et al. Geriatric assessment in older alloHCT recipients: association of functional and cognitive impairment with outcomes. Blood Adv. 2020;4(12):2810-2820.
View Articletitled, Olin RL, Fretham C, Pasquini MC, et al. Geriatric assessment in older alloHCT recipients: association of functional and cognitive impairment with outcomes. <em>Blood Adv</em>. 2020;4(12):2810-2820.
Kahn JM, Brazauskas R, Tecca HR, et al. Subsequent neoplasms and late mortality in children undergoing allogeneic transplantation for nonmalignant diseases. Blood Adv. 2020;4(9):2084-2094.
View Articletitled, Kahn JM, Brazauskas R, Tecca HR, et al. Subsequent neoplasms and late mortality in children undergoing allogeneic transplantation for nonmalignant diseases. <em>Blood Adv.</em> 2020;4(9):2084-2094.
Supplemental data
Deen D, Butter F, Daniels DE, et al. Identification of the transcription factor MAZ as a regulator of erythropoiesis. Blood Adv. 2021;5(15):3002-3015.
View Articletitled, Deen D, Butter F, Daniels DE, et al. Identification of the transcription factor MAZ as a regulator of erythropoiesis. <em>Blood Adv.</em> 2021;5(15):3002-3015.
Duque-Afonso J, Ewald S, Ihorst G, et al. The impact of pulmonary function in patients undergoing autologous stem cell transplantation. Blood Adv. 2021;5(21):4327-4337.
View Articletitled, Duque-Afonso J, Ewald S, Ihorst G, et al. The impact of pulmonary function in patients undergoing autologous stem cell transplantation. <em>Blood Adv</em>. 2021;5(21):4327-4337.
All Issues

Advertisement

Balancing considerations and qualifying conclusions for cost-effectiveness of therapies for relapsed/refractory follicular lymphoma
Clinical and epidemiological features of paroxysmal cold hemoglobinuria: a systematic review
Pegcetacoplan controls hemolysis in complement inhibitor–naive patients with paroxysmal nocturnal hemoglobinuria
Tumor-expressed factor VII is associated with survival and regulates tumor progression in breast cancer
Mitochondrial pyruvate dehydrogenase kinases contribute to platelet function and thrombosis in mice by regulating aerobic glycolysis

Advertisement

Advertisement

  • American Society of Hematology
  • 2021 L Street NW, Suite 900
  • Washington, DC 20036
  • TEL +1 202-776-0544
  • FAX +1 202-776-0545

ASH Publications

American Society of Hematology

Copyright ©2023 by American Society of Hematology
 
Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal

Advertisement